Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 8047183, 9 pages
https://doi.org/10.1155/2017/8047183
Review Article

Meta-Analysis of the Relationship between NM23 Expression to Gastric Cancer Risk and Clinical Features

Department of Clinical Laboratory, The Affiliated Tumor Hospital of Guangxi Medical University, Nanning, Guangxi, China

Correspondence should be addressed to Bo Zhu; moc.621@nnxgobuhz

Received 13 December 2016; Accepted 12 February 2017; Published 16 March 2017

Academic Editor: Xin-yuan Guan

Copyright © 2017 Min Fang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-Tieulent, and A. Jemal, “Global cancer statistics, 2012,” CA Cancer Journal for Clinicians, vol. 65, no. 2, pp. 87–108, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Zhang, K. Liu, F. Wang, X. Wen, and X. Song, “Association between CYP2E1 polymorphisms and risk of gastric cancer: an updated meta-analysis of 32 case-control studies,” Molecular and Clinical Oncology, vol. 4, no. 6, pp. 1031–1038, 2016. View at Publisher · View at Google Scholar
  3. J. A. Ajani, “Gastroesophageal cancers: progress and problems,” Journal of the National Comprehensive Cancer Network, vol. 6, no. 9, pp. 813–814, 2008. View at Google Scholar · View at Scopus
  4. Y. Guan-Zhen, C. Ying, N. Can-Rong, W. Guo-Dong, Q. Jian-Xin, and W. Jie-Jun, “Reduced protein expression of metastasis-related genes (nm23, KISS1, KAI1 and p53) in lymph node and liver metastases of gastric cancer,” International Journal of Experimental Pathology, vol. 88, no. 3, pp. 175–183, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. J.-Q. Chen, W.-H. Zhan, Y.-L. He et al., “Expression of heparanase gene, CD44v6, MMP-7 and nm23 protein and their relationship with the invasion and metastasis of gastric carcinomas,” World Journal of Gastroenterology, vol. 10, no. 6, pp. 776–782, 2004. View at Google Scholar · View at Scopus
  6. N.-Y. Hsu, K.-C. Chow, W.-J. Chen, C.-C. Lin, F.-F. Chou, and C.-L. Chen, “Expression of nm23 in the primary tumor and the metastatic regional lymph nodes of patients with gastric cardiac cancer,” Clinical Cancer Research, vol. 5, no. 7, pp. 1752–1757, 1999. View at Google Scholar · View at Scopus
  7. P. S. Steeg, G. Bevilacqua, L. Kopper et al., “Evidence for a novel gene associated with low tumor metastatic potential,” Journal of the National Cancer Institute, vol. 80, no. 3, pp. 200–204, 1988. View at Publisher · View at Google Scholar · View at Scopus
  8. J.-C. Marshall, J. Collins, N. Marino, and P. Steeg, “The Nm23-H1 metastasis suppressor as a translational target,” European Journal of Cancer, vol. 46, no. 7, pp. 1278–1282, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Boissan, O. De Wever, F. Lizarraga et al., “Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells,” Cancer Research, vol. 70, no. 19, pp. 7710–7722, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Boissan, S. Dabernat, E. Peuchant, U. Schlattner, I. Lascu, and M.-L. Lacombe, “The mammalian Nm23/NDPK family: from metastasis control to cilia movement,” Molecular and Cellular Biochemistry, vol. 329, no. 1-2, pp. 51–62, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Yang, B.-Z. Chen, D.-F. Li et al., “Reduced NM23 protein level correlates with worse clinicopathologic features in colorectal cancers: a meta-analysis of pooled data,” Medicine, vol. 95, no. 4, p. e2589, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Nakayama, A. Ohtsuru, K. Nakao et al., “Expression in human hepatocellular carcinoma of nucleoside diphosphate kinase, a homologue of the nm23 gene product,” Journal of the National Cancer Institute, vol. 84, no. 17, pp. 1349–1354, 1992. View at Publisher · View at Google Scholar · View at Scopus
  13. O. Takeda, M. Handa, T. Uehara et al., “An increased NM23H1 copy number may be a poor prognostic factor independent of LOH on 1p in neuroblastomas,” British Journal of Cancer, vol. 74, no. 10, pp. 1620–1626, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. D. N. T. Aryee, I. Simonitsch, I. Mosberger et al., “Variability of nm23-H1/NDPK-A expression in human lymphomas and its relation to tumour aggressiveness,” British Journal of Cancer, vol. 74, no. 11, pp. 1693–1698, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Gazzeri, E. Brambilla, A. Negoescu et al., “Overexpression of nucleoside diphosphate/kinase A/nm23-H1 protein in human lung tumors: association with tumor progression in squamous carcinoma,” Laboratory Investigation, vol. 74, no. 1, pp. 158–167, 1996. View at Google Scholar · View at Scopus
  16. D. K. Dhar, H. Kubota, H. Tabara et al., “nm23 in the primary and metastatic sites of gastric carcinoma. Relation to AFP-producing carcinoma,” Oncology, vol. 56, no. 2, pp. 122–128, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Radovic, M. Doric, A. Hukic, M. Babic, S. Kuskunovic, and N. Spahovic, “Immunohistochemical expression and significance of NM23 suppressor protein in primary gastric adenocarcinoma,” Bosnian Journal of Basic Medical Sciences, vol. 13, no. 2, pp. 72–77, 2013. View at Google Scholar
  18. D. Jackson, I. R. White, and R. D. Riley, “Quantifying the impact of between-study heterogeneity in multivariate meta-analyses,” Statistics in Medicine, vol. 31, no. 29, pp. 3805–3820, 2012. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  19. E. Zintzaras and J. P. A. Ioannidis, “HEGESMA: genome search meta-analysis and heterogeneity testing,” Bioinformatics, vol. 21, no. 18, pp. 3672–3673, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. Y.-W. Wang, M.-L. Zhu, R.-F. Wang et al., “Predictable factors for lymph node metastasis in early gastric cancer analysis of clinicopathologic factors and biological markers,” Tumor Biology, vol. 37, no. 7, pp. 8567–8578, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Okayama, K. Kumamoto, K. Saitou et al., “CD44v6, MMP-7 and nuclear Cdx2 are significant biomarkers for prediction of lymph node metastasis in primary gastric cancer,” Oncology Reports, vol. 22, no. 4, pp. 745–755, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. S. P. Mönig, B. Nolden, T. Lübke et al., “Clinical significance of nm23 gene expression in gastric cancer,” Anticancer Research, vol. 27, no. 4, pp. 3029–3033, 2007. View at Google Scholar · View at Scopus
  23. Y.-Q. Yang, L. Wu, J.-X. Chen et al., “Relationship between nm23H1 genetic instability and clinical pathological characteristics in Chinese digestive system cancer patients,” World Journal of Gastroenterology, vol. 14, no. 36, pp. 5549–5556, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. G. F. Ding, J. C. Li, C. S. Li, Y. F. Xu, Y. Sun, and X. R. Chen, “Study on the correlation between the expressions of nm23H1 mRNA, VEGF-C mRNA and lymphatic metastases, survival rate with gastric cancer,” Fen zi xi bao sheng wu xue bao = Journal of molecular cell biology / Zhongguo xi bao sheng wu xue xue hui zhu ban, vol. 39, no. 1, pp. 46–54, 2006. View at Google Scholar · View at Scopus
  25. G.-Z. Yu, J.-J. Wang, Y. Chen, C.-R. Ni, and M.-H. Zhu, “Expressions of nm23, P53 and S100A4 proteins and their relationships with metastasis potential in gastric carcinoma,” Chinese Journal of Gastrointestinal Surgery, vol. 9, no. 2, pp. 165–169, 2006. View at Google Scholar · View at Scopus
  26. Y.-J. Liu, P.-S. Yan, J. Li, and J.-F. Jia, “Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer,” World Journal of Gastroenterology, vol. 11, no. 42, pp. 6601–6606, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. J.-Q. Chen, W.-H. Zhan, Y.-L. He, S.-R. Cai, J.-S. Peng, and Z.-X. Chen, “Prediction of lymph node metastasis with binary logistic regression in gastric carcinoma,” Chinese Journal of Gastrointestinal Surgery, vol. 8, no. 5, pp. 436–439, 2005. View at Google Scholar · View at Scopus
  28. Y. Li, J.-H. Zhang, G. Kuang et al., “Expression of MUC1, CD44v6, nm23 in gastric carcinomas and regional lymph node tissues and their association with invasion, metastasis, and prognosis of the tumor,” Ai zheng = Aizheng = Chinese journal of cancer, vol. 22, no. 9, pp. 985–989, 2003. View at Google Scholar · View at Scopus
  29. K. E. Lee, H.-J. Lee, Y. H. Kim et al., “Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer,” Japanese Journal of Clinical Oncology, vol. 33, no. 4, pp. 173–179, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Terada, T. Yasutake, S. Nakamura et al., “Clinical significance of nm23 expression and chromosome 17 numerical aberrations in primary gastric cancer,” Medical Oncology, vol. 19, no. 4, pp. 239–248, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. S.-Q. Ji, Y.-W. Hua, J. Zhuang et al., “Significance of COX-2, p53, proliferating cell nuclear antigen and nm23 expressions in gastric cancer and its behavior,” Ai zheng = Aizheng = Chinese journal of cancer, vol. 21, no. 6, pp. 619–624, 2002. View at Google Scholar · View at Scopus
  32. Y.-K. Wang, X.-L. Ji, and N.-X. Ma, “nm23 expression in gastric carcinoma and its relationship with lymphoproliferation,” World Journal of Gastroenterology, vol. 5, no. 1, pp. 87–89, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. C. H. Yoo, S. H. Noh, H. Kim, H. Y. Lee, and J. S. Min, “Prognostic significance of CD44 and nm23 expression in patients with stage II and stage IIIA gastric carcinoma,” Journal of Surgical Oncology, vol. 71, no. 1, pp. 22–28, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. C.-S. Wang, K.-H. Lin, Y.-C. Hsu, and S. Hsueh, “Distant metastasis of gastric cancer is associated with elevated expression of the antimetastatic nm23 gene,” Cancer Letters, vol. 128, no. 1, pp. 23–29, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Yeung, C. Soon Lee, P. Marr, M. Sarris, and D. Fenton-Lee, “Nm23 gene expression in gastric carcinoma: an immunohistochemical study,” Australian and New Zealand Journal of Surgery, vol. 68, no. 3, pp. 180–182, 1998. View at Publisher · View at Google Scholar · View at Scopus
  36. W. Muller, A. Schneiders, G. Hommel, and H. E. Gabbert, “Expression of nm23 in gastric carcinoma: association with tumor progression and poor prognosis,” Cancer, vol. 83, no. 12, pp. 2481–2487, 1998. View at Publisher · View at Google Scholar · View at Scopus
  37. Z. Wei, Y. Wu, and Z. Zhai, “Immunohistochemical study of p53, c-erbB-2 and nm23 proteins in human gastric cancer,” Chinese Journal of Oncology, vol. 19, no. 5, pp. 378–381, 1997. View at Google Scholar · View at Scopus
  38. I. Songun, C. J. H. Van De Velde, J. Hermans et al., “Expression of oncoproteins and the amount of eosinophilic and lymphocytic infiltrates can be used as prognostic factors in gastric cancer,” British Journal of Cancer, vol. 74, no. 11, pp. 1783–1788, 1996. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Ura, R. Denno, and K. Hirata, “The significance of nm23 protein expression in human gastric carcinomas,” Surgery Today, vol. 26, no. 12, pp. 957–965, 1996. View at Publisher · View at Google Scholar · View at Scopus
  40. K. M. Kim, A. Lee, H. S. Chae, and S. I. Shim, “Expression of p53 and NDP-K/nm23 in gastric carcinomas—association with metastasis and clinicopathologic parameters,” Journal of Korean Medical Science, vol. 10, no. 6, pp. 406–413, 1995. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Zhang, S. Ye, and H. Lin, “Gastric cancer with P53 overexpression and nm23 low-expression has high potential for lymph node metastasis,” Chinese Journal of Oncology, vol. 17, no. 6, pp. 418–421, 1995. View at Google Scholar · View at Scopus
  42. P. Soliani, S. Ziegler, A. Romani et al., “Prognostic significance of nm23 gene product expression in patients with colorectal carcinoma treated with radical intent,” Oncology Reports, vol. 11, no. 6, pp. 1193–1200, 2004. View at Google Scholar · View at Scopus
  43. N. Marino, J. Nakayama, J. W. Collins, and P. S. Steeg, “Insights into the biology and prevention of tumor metastasis provided by the Nm23 metastasis suppressor gene,” Cancer and Metastasis Reviews, vol. 31, no. 3-4, pp. 593–603, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. C.-H. Lin, V. Dammai, B. Adryan, and T. Hsu, “Interaction between Nm23 and the tumor suppressor VHL,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 388, no. 2, pp. 143–152, 2015. View at Publisher · View at Google Scholar · View at Scopus